Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-17

FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approved a supplemental application for oxymorphone hydrochloride from Amneal Pharmaceuticals of New York LLC. The action confirms approval of the produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxymorphone hydrochloride (Oxymorphone hydrochloride)

Snippet

SUPPL AP for OXYMORPHONE HYDROCHLORIDE (OXYMORPHONE HYDROCHLORIDE)